close

Syncom Health

Know More
NSEBSE

1.850.00 (0.00%)

21st Aug 2020

87.85000.00 (0.00%)

15th Feb 2010

BSE : 533157

NSE : SYNCOM

Sector :

ISIN Code :

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 15 2010 | 12:00 AM IST

Market Cap (₹ Cr)

NaN

Turnover (₹ Cr)

NaN

Volume (Shares)

292487

52-WK High

1.95

52-WK High Date

29 Sep 2023

52-WK Low

0.00

52-WK Low Date

29 Sep 2023

All Time High

All Time High Date

29 Sep 2023

All Time Low

All Time Low Date

29 Sep 2023

Syncom Health

Syncom Healthcare Ltd is engaged in the manufacture marketing and trade of pharmaceutical formulations. The company manufactures a range of products such as Ethical drugs Generic drugs over the counter drugs (OTC) and Herbal formulations in various dosage forms and markets them under the trade mark Syncom.The company also undertakes contract manufacturing for large variety of pharmaceutical formulations for a number of other pharmaceutical companies of national and international repute such as Lupin Ltd Nicholas Piramal India Ltd Galpha Laboratories Ltd Percos India Pvt Ltd etc (under their own brands) located in India.The company manufactures various dosage forms which include tablets capsules eye/ ear drops ointment and creams and dry syrups. They have an established product-marketing network covering both metro and mini-metro cities which enable them to reach their existing and potential customers through their network of distributors and dealers spread across the country. Syncom Healthcare Ltd was incorporated on July 29 2002 for marketing of pharmaceutical formulations. The company was promoted by Ajay S Bankda and Jyoti Bankda. The company received the certificate for commencement of business on August 2 2002. Initially the company started their journey with the marketing of the pharmaceuticals products manufactured by others under their own brand. In May 10 2004 the company entered into a Deed of Assignment of Trade Marks with Syncom Formulations (India) Ltd through which Syncom Formulations transferred and assigned various registered & pending trade marks & copy right for artistic works of various labels to the company. The company took over various domestic brands and domestic marketing network of Syncom Formulations.In the year 2005 the company initiated setting of a manufacturing unit at Selaqui Dehradun in the state of Uttarakhand. In the year 2006 they set up a state-of-art manufacturing unit at Dehradun in Uttarakhand. The unit commenced commercial production in November 2006. They produced all types of formulations namely tablets capsules eye/ ear drops ointments dry powder liquid syrup/ suspension and creams.In the year 2007 the company entered into an agreement for contract manufacturing with Lupin Ltd Galpha Laboratories Nicholas Piramal etc for manufacturing their various range of products.In March 2010 the company entered into new contract manufacturing agreement with Kilitch Drugs to undertake manufacturing of products at its Dehradun facility. This will increase the volume of business with the existing reputed contract manufacturers.The company entered into an MoU with Advanced Techno Lab based in Democratic Republic of Congo Africa toll undertake product marketing activities in Congo. The company is in the process of setting up a new unit at Indore Special Economic Zone at Pithampur in Madhya Pradesh. The company has already obtained the Letter of Approval for setting up a pharmaceutical formulation unit in Indore SEZ.

Syncom Health - Key Fundamentals

PARAMETER VALUES
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Year Low/High

0.00

0.00

All time Low/High

0.65

162.00

Share Price Returns

Period BSENSE SENSEXNIFTY
%%%
This stock has been delisted. Data presented here are the latest available.

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
24-06-2021LESLIE GREG LOBOBSEBUY2170004.33
04-02-2021ALPHA LEON ENTERPRISES LLPBSEBUY4849823.12
04-02-2021VLS FINANCE LTD.BSESELL5000003.12
06-01-2021ANITA RAJKUMAR BEHRBSESELL3805223.16
15-12-2020ARCADIA SHARE & STOCK BROKERS PVT. LTDBSESELL2039002.52
10-07-2020PRATIK BANKDABSESELL26381532.69
10-07-2020SAUMIL ARVINDBHAI BHAVNAGARIBSEBUY24000002.69
10-07-2020VISHWAMURTE TRAD INVEST PE LTDBSEBUY2032002.69
02-07-2020ALPHA LEON ENTERPRISES LLPBSESELL2500043.45
01-07-2020ALPHA LEON ENTERPRISES LLPBSEBUY63.24

Load More

This stock has been delisted. Data presented here are the latest available.
This stock has been delisted. Data presented here are the latest available.

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Independent Director : Sunita Garg

Independent Director : Tushar Patodia

Managing Director : Ajay Shankarlal Bankda

Director : Manoj Negi

Independent Director : Bhishampal Singh Yadav